Company Filing History:
Years Active: 1998
Title: Alden Keith Henderson: Innovator in Neurokinin Receptor Technology
Introduction
Alden Keith Henderson is a notable inventor based in Tucson, AZ. He has made significant contributions to the field of neuropeptide research, particularly through his innovative patent related to neurokinin receptors. His work has implications for various applications in pharmacology and biotechnology.
Latest Patents
Henderson holds a patent for a method titled "Neurokinin receptor cell lines." This invention focuses on producing high-level expression of neuropeptide receptors and stable cell lines useful in research and therapeutic applications. The method involves culturing a cell line that contains amplified copies of a cDNA sequence encoding a neuropeptide receptor, utilizing an expression control sequence derived from the β-actin transcriptional control element. This patent showcases his expertise in molecular biology and cell line development.
Career Highlights
Alden Keith Henderson is currently associated with Merrell Pharmaceuticals, Inc., where he applies his knowledge and skills in the pharmaceutical industry. His work at Merrell Pharmaceuticals has allowed him to contribute to the development of innovative solutions in drug discovery and development.
Collaborations
Throughout his career, Henderson has collaborated with esteemed colleagues, including Josephine Yuen-Wai Lai and Stephen H Buck. These collaborations have fostered a productive environment for research and innovation, enhancing the impact of their collective work in the field.
Conclusion
Alden Keith Henderson's contributions to neurokinin receptor technology exemplify the importance of innovation in the pharmaceutical industry. His patent and collaborative efforts highlight his commitment to advancing scientific knowledge and improving therapeutic options.